These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7931226

  • 1. Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity.
    Chiueh CC, Huang SJ, Murphy DL.
    J Neural Transm Suppl; 1994; 41():189-96. PubMed ID: 7931226
    [Abstract] [Full Text] [Related]

  • 2. Enhanced hydroxyl radical generation by 2'-methyl analog of MPTP: suppression by clorgyline and deprenyl.
    Chiueh CC, Huang SJ, Murphy DL.
    Synapse; 1992 Aug; 11(4):346-8. PubMed ID: 1323883
    [Abstract] [Full Text] [Related]

  • 3. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 4. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE.
    Life Sci; 1988 Oct; 42(3):263-71. PubMed ID: 3121972
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Oct; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 6. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
    Sziráki I, Kardos V, Patthy M, Pátfalusi M, Gaál J, Solti M, Kollár E, Singer J.
    J Neural Transm Suppl; 1994 Oct; 41():207-19. PubMed ID: 7931228
    [Abstract] [Full Text] [Related]

  • 7. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT, Irwin I, Delanney LE, Langston JW.
    J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
    [Abstract] [Full Text] [Related]

  • 8. Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.
    Wu RM, Chiueh CC, Pert A, Murphy DL.
    Eur J Pharmacol; 1993 Oct 26; 243(3):241-7. PubMed ID: 8276076
    [Abstract] [Full Text] [Related]

  • 9. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.
    Chiueh CC, Wu RM, Mohanakumar KP, Sternberger LM, Krishna G, Obata T, Murphy DL.
    Ann N Y Acad Sci; 1994 Nov 17; 738():25-36. PubMed ID: 7832434
    [Abstract] [Full Text] [Related]

  • 10. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 17; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 11. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
    Basma AN, Heikkila RE, Nicklas WJ, Giovanni A, Geller HM.
    J Neurochem; 1990 Sep 17; 55(3):870-7. PubMed ID: 2384758
    [Abstract] [Full Text] [Related]

  • 12. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC.
    Nature; 1990 Sep 17; 311(5985):467-9. PubMed ID: 6332989
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM, Mohanakumar KP, Murphy DL, Chiueh CC.
    Ann N Y Acad Sci; 1994 Nov 17; 738():214-21. PubMed ID: 7832430
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Heikkila RE, Kindt MV, Sonsalla PK, Giovanni A, Youngster SK, McKeown KA, Singer TP.
    Proc Natl Acad Sci U S A; 1988 Aug 17; 85(16):6172-6. PubMed ID: 3137566
    [Abstract] [Full Text] [Related]

  • 19. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1990 Sep 17; 55(3):981-8. PubMed ID: 2117053
    [Abstract] [Full Text] [Related]

  • 20. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
    Kindt MV, Heikkila RE.
    Life Sci; 1986 Apr 21; 38(16):1459-62. PubMed ID: 3084895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.